Posts filed under: Pharmaceuticals

Register to receive a free Global Immunology Drugs Market Report Suite 2018-2024 report synopsis and brochure In a new series of reports by iData Research, it was revealed that in 2017, the U.S. immunology market was valued at over $34 billion. A...
Continue Reading →
Register to receive a free Immunology Drugs Market for the US 2018-2024 report synopsis and brochure SetPoint Medical has launched a pilot trial to assess the safety and efficacy of a bioelectronics device in patients, who are suffering from rheumatoid arthritis and...
Continue Reading →
Overall, the U.S. immunology drug market is projected to exceed an estimated $38 billion by 2023 due to the entry of new biosimilars and JAK inhibitors into the market....
Continue Reading →
EADV is a non-profit association whose mission is to advance excellence in clinical care, research, education and training in the fields of Dermatology and Venereology....
Continue Reading →
Biosimilars are, as the name would suggest, highly similar and are a more affordable alternative to biologics that is poised to influence the current dynamics of the immunology market. ...
Continue Reading →
The U.S. immunology drug market is expected to grow to $68 billion by 2023 due to the entry of new biosimilars and JAK inhibitors....
Continue Reading →
Sandoz believes the comprehensive data package submitted to the FDA for review confirms that our biosimilar rituximab matches the reference medicine in terms of safety, efficacy and quality...
Continue Reading →
Agreements Provide Non-Exclusive License to Amgen for HUMIRA-Related Intellectual Property in the U.S. Effective Jan. 31, 2023, And in Other Markets on Different Dates...
Continue Reading →
The new drug, Imraldi, marks the third European Commission approval for “biosimilar” versions from the joint venture, Samsung Bioepis, of drugs in a class known as TNF inhibitors....
Continue Reading →
CAR T-cell therapy approved to treat certain children and young adults with B-cell acute lymphoblastic leukemia - Oncodesign is expanding its service offering in immunology and infectious diseases...
Continue Reading →
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link